id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
EPA-HQ-OPP-2009-0846-0087,EPA,EPA-HQ-OPP-2009-0846,Diquat Dibromide Comment Period Extension,Other,,2017-07-20T04:00:00Z,2017,7,2017-07-20T04:00:00Z,2017-08-24T03:59:59Z,2018-01-12T02:02:23Z,,0,0,090000648294ea1e
EPA-HQ-OPP-2009-0846-0082,EPA,EPA-HQ-OPP-2009-0846,"Diquat Dibromide Usage Summary, Impacts and Resistance Management",Supporting & Related Material,Memorandum,2017-05-25T04:00:00Z,2017,5,,,2017-05-25T20:31:51Z,,0,0,09000064822a1f2e
EPA-HQ-OPP-2009-0846-0081,EPA,EPA-HQ-OPP-2009-0846,"Registration Reviews: Boric Acid/Sodium Salts, Clethodim, Diquat Dibromide, Ethephon, Fenitrothion, Hexazinone, Hymexazol, Methoxyfenozide, Pronamide, and Trimedlure",Notice,,2017-05-25T04:00:00Z,2017,5,2017-05-25T04:00:00Z,2017-08-24T03:59:59Z,2017-08-24T13:07:17Z,2017-10670,0,0,0900006482616f50
EPA-HQ-OPP-2009-0846-0083,EPA,EPA-HQ-OPP-2009-0846,Response to Comments on the Diquat Dibromide Drat Human Health Risk Assessment for Registration Review,Supporting & Related Material,Comment Response,2017-05-25T04:00:00Z,2017,5,,,2017-05-25T20:31:51Z,,0,0,09000064822a1f2f
EPA-HQ-OPP-2009-0846-0085,EPA,EPA-HQ-OPP-2009-0846,Diquat Dibromide:  Response to Comments on the EFED Preliminary Risk Assessment,Supporting & Related Material,Comment Response,2017-05-25T04:00:00Z,2017,5,,,2017-05-25T20:31:51Z,,0,0,09000064822a1f31
EPA-HQ-OPP-2009-0846-0084,EPA,EPA-HQ-OPP-2009-0846,Diquat Dibromide:  Revised Occupational and Residential Exposure Assessment  for Registration Review,Supporting & Related Material,Risk Assessment,2017-05-25T04:00:00Z,2017,5,,,2017-05-25T20:31:51Z,,0,0,09000064822a1f30
EPA-HQ-OPP-2009-0846-0086,EPA,EPA-HQ-OPP-2009-0846,Diquat Dibromide Proposed Interim Registration Review Decision Case Number 0288,Supporting & Related Material,Decision,2017-05-25T04:00:00Z,2017,5,,,2017-05-25T20:31:51Z,,0,0,0900006482313451